R, A., R, R., A, M., D, B., V, G., E, B., . . . C, B. (2022). Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis. Frontiers in neurology, 13, 872396. https://doi.org/10.3389/fneur.2022.872396
Chicago Style (17th ed.) CitationR, Amoriello, et al. "Investigating Serum SHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis." Frontiers in Neurology 13 (2022): 872396. https://doi.org/10.3389/fneur.2022.872396.
MLA (9th ed.) CitationR, Amoriello, et al. "Investigating Serum SHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis." Frontiers in Neurology, vol. 13, 2022, p. 872396, https://doi.org/10.3389/fneur.2022.872396.